RAHWAY, NJ-To help serve an increasingly health-conscious public, Merck & Co. has launched its first consumer reference, The Merck Manual of Medical Information-Home Edition.
RAHWAY, NJTo help serve an increasingly health-conscious public, Merck & Co. has launched its first consumer reference, The Merck Manual of Medical InformationHome Edition.
Based on its physician reference, The Merck Manual of Diagnosis and Therapy, but written in everyday language, the 1,509-page Home Edition provides authoritative, up-to-date information on more than 3,000 medical conditions. The Home Edition has been more than five years in the making, as the more than 200 contributors translated the Merck Manual into plain English.
Readers can sample the Home Edition on the Internet at the Merck web site (http://www.merck.com). The Home Edition can be ordered by calling 1-800-999-3633.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.